Category: MDMA
Canada. Again. This time in Whistler: A 20-year-old male had been found unconscious by friends. When police arrived, Whistler Fire Rescue Service and Emergency Health Services personnel were performing CPR, but failed to revive the victim, who was pronounced dead...
Read on »
Posted by DrugMonkey at 9:07 AM • 0 Comments • 0 TrackBacks
Category: NIH
Anything that encourages scientists to help with NIH grant review is a GoodThing.
Read on »
Posted by DrugMonkey at 1:01 PM • 0 Comments • 0 TrackBacks
Category: #FWDAOTI
The smart bet is that this complete and utter screwup is driven entirely by some scheme to monetize rather than by what they think users actually want.
Read on »
Posted by DrugMonkey at 1:05 PM • 8 Comments • 0 TrackBacks
Category: Cannabis
Another part of the Trojan horse strategy.
Read on »
Posted by DrugMonkey at 4:15 PM • 49 Comments • 0 TrackBacks
Category: Science Publication
People argue back and forth over whether Impact Factor of journals, the h-index, Total Cites, specific paper cites, etc should be used as the primary assessment of scientific quality. Many folks talk out of both sides of their mouths, bemoaning the irrelevance of journal Impact Factor while beavering away to get their papers into those journals and using the criterion to judge others. In this you will note people arguing the case that makes their CV look the best. I have a proposal:
Read on »
Posted by DrugMonkey at 1:48 PM • 18 Comments • 0 TrackBacks
Category: Grant Review
Finally. An opinion bit written by a senior investigator who actually seems to have a brain in his head and is not blinded by selfishness. The argument that grants should be funded only on the basis of priority scores is...
Read on »
Posted by DrugMonkey at 2:40 PM • 3 Comments • 0 TrackBacks
Category: Science Publication
There's a new entry up over at the Golden Thoughts blog (she's a nephrologist, so..yes) that talks about the all important journal Impact Factor, Harold Varmus' opinion of same and journals gaming the system. Dr. Varmus pointed out that many...
Read on »
Posted by DrugMonkey at 1:37 PM • 11 Comments • 0 TrackBacks
Category: Grantsmanship
To contrast with PhysioProf, I think the ordering of events is not strictly dependent on specific subfield. In my case it has to do with ongoing specific circumstances in the laboratory and my ongoing research findings and interests.
Read on »
Posted by DrugMonkey at 12:18 PM • 2 Comments • 0 TrackBacks
Category: Tribe of Science
Not only because it is the source of some of my own queasiness when reading (and trying to discuss) Gladwell, but also because I fall into this trap when talking about science careers.
Read on »
Posted by DrugMonkey at 8:58 PM • 23 Comments • 0 TrackBacks
Category: Careerism
PhysioProf has the call on a letter published in Science Magazine. One Professor Debomoy K. Lahiri, Ph.D. (Univ website; Research Crossroads) is kvetching about the NIH policy to support previously unfunded investigators and as usual comes off looking idiotic. Increasing...
Read on »
Posted by DrugMonkey at 5:57 PM • 22 Comments • 0 TrackBacks